Effect of combination therapy with sodium ozagrel and panax ginseng on transient cerebral ischemia model in rats.

Sodium ozagrel (SO) prevents platelet aggregation and vasoconstriction in the cerebral ischemia. It plays an important role in the prevention of brain damage induced by cerebral ischemia/reperfusion. Recently, many animal studies have suggested that the Panax ginseng (PG) has neuroprotective effects in the ischemic brain. In this study, we assessed the neuroprotective effects that come from a combination therapy of SO and PG in rat models with middle cerebral artery occlusion (MCAO). Animals with MCAO were assigned randomly to one of the following four groups: (1) control (Con) group, (2) SO group (3 mg/kg, intravenously), (3) PG group (200 mg/kg, oral feeding), and (4) SO + PG group. The rats were subjected to a neurobehavior test including adhesive removal test and rotarod test at 1, 3, 7, 10, and 15 days after MCAO. The cerebral ischemic volume was quantified by Metamorph imaging software after 2-3-5-triphenyltetrazolium (TTC) staining. The neuronal cell survival and astrocytes expansion were assessed by immunohistofluorescence staining. In the adhesive removal test, the rats of PG or SO + PG group showed significantly better performance than those of the control group (Con: 88.1 ± 24.8, PG: 43.6 ± 11, SO + PG: 11.8 ± 7, P < .05). Notably, the combination therapy group (SO + PG) showed better performance than the SO group alone (SO: 56 ± 12, SO + PG: 11.8 ± 7, P < .05). In TTC staining for infarct volume, cerebral ischemic areas were also significantly reduced in the PG group and SO + PG group (Con: 219 ± 32, PG: 117 ± 8, SO + PG: 99 ± 11, P < .05). Immunohistofluorescence staining results showed that the group which received SO + PG group therapy had neuron cells in the normal range. They also had a low number of astrocytes and apoptotic cells compared with the control or SO group in the peri-infarction area. During astrocytes staining, compared to the SO + PG group, the PG group showed only minor differences in the number of NeuN-positive cells and quantitative analysis of infarct volume. In conclusion, these studies showed that in MCAO rat models, the combination therapy with SO and PG may provide better neuroprotective effects such as higher neuronal cell survival and inhibition of astrocytes expansion than monotherapy with SO alone.
AuthorsSang In Park, Dong-Kyu Jang, Young-Min Han, Yun-Young Sunwoo, Moon-Seo Park, Yong-An Chung, Lee-So Maeng, Ruth Im, Min-Wook Kim, Sin-Soo Jeun, Kyung-Sool Jang
JournalJournal of biomedicine & biotechnology (J Biomed Biotechnol) Vol. 2010 Pg. 893401 ( 2010) ISSN: 1110-7251 [Electronic] United States
PMID21274269 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Nuclear
  • Drugs, Chinese Herbal
  • Fibrinolytic Agents
  • Methacrylates
  • Nerve Tissue Proteins
  • NeuN protein, rat
  • Neuroprotective Agents
  • ozagrel
  • Animals
  • Antigens, Nuclear (metabolism)
  • Apoptosis (drug effects)
  • Astrocytes (pathology)
  • Behavior, Animal (drug effects)
  • Disease Models, Animal
  • Drug Synergism
  • Drug Therapy, Combination
  • Drugs, Chinese Herbal (pharmacology)
  • Fibrinolytic Agents (pharmacology)
  • Infarction, Middle Cerebral Artery (pathology)
  • Ischemic Attack, Transient (drug therapy, metabolism, pathology)
  • Methacrylates (pharmacology)
  • Nerve Tissue Proteins (metabolism)
  • Neurons (pathology)
  • Neuroprotective Agents (pharmacology)
  • Panax
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: